In one trial 2 patients with familial amyotrophic lateral sclerosis (ALS) and mutations in the gene encoding superoxide dismutase 1 (SOD1) were treated with a single intrathecal infusion of an AAV vector encoding a microRNA targeting SOD1. The gene discussed is SOD1; the disease is familial amyotrophic lateral sclerosis.